Fedblog
Drug Bust.
Here's the FDA reservation. And there's agency scientist David J. Graham way, way off it in the distance. Graham headed to the Hill yesterday to lob a grenade into the whole Vioxx mess, calling it a "profound regulatory failure" and saying the agency is "virtually defenseless" against preventing a similar situation from arising again. In fact, he went as far as naming five drugs he thought were similarly dangerous: Crestor, Meridia, Bextra, Accutane and Serevent. This unexpectedly harsh assessment forced Dr. Steven Galston, acting director of the FDA's Center for Drug Evaluation and Research, to take the extraordinary step of going on NBC's Today show this morning to "categorically reject" Graham's claims. Let's face it: It just hasn't been a good week for muzzling civil servants.
By using this service you agree not to post material that is obscene, harassing, defamatory, or otherwise objectionable. Although GovExec.com does not monitor comments posted to this site (and has no obligation to), it reserves the right to delete, edit, or move any material that it deems to be in violation of this rule.
TSP's G Fund Helps Delay Debt Ceiling
CBP Could Escape Furloughs
Feds Flock to TSP's L Funds
EIG 2013 as Told by Your Tweets
Boldly Go Where No Fed's Gone Before
The Big Squeeze: Defense Under Sequester
Cutting costs: Inside the effort to improve the efficiency of federal operations
Sponsored
3 Ways Data is Improving DoD Performance
Research Report: Powering Continuous Monitoring Through Big Data
Need to Know Memo: Big Data
